Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
J Med Food ; 26(4): 262-269, 2023 Apr.
Article in English | MEDLINE | ID: mdl-37071614

ABSTRACT

This study aims to assess the effectiveness and safety of plant-derived food supplement Ich Nieu Khang (INK) as a dietary supplement for overactive bladder (OAB) symptoms. A total of 50 patients 18-80 years of age with the diagnosis and symptoms of the OAB were enrolled in the study and followed up for 30 days. The INK treatment efficacy, in terms of changes in nocturnal and day-time urination frequency, urination incontinence episodes, level of OAB symptoms according to Homma's OABSS scale, sleep quality according to Pittsburg Sleep Quality Index (PSQI), and possible side effects of the INK phytotherapy, was evaluated. INK significantly improved all OAB symptoms scores with a reduction of average nocturia from 4.06 ± 1.53 to 1.14 ± 0.94, the daily average urination urgency from 7.67 ± 5.00 to 5. 82 ± 3.70, the daily average frequency of urination from 9.96 ± 4.04 to 8.00 ± 3.70, weekly average incontinence of urination from 0.92 ± 1.56 to 0.60 ± 1.02, and OABSS Homma's score decreased from 9.31 ± 1.44 to 6.8 ± 2.21. INK phytotherapy also resulted in sleep quality improvement by PSQI score decreasing from 13.11 ± 1.33 to 10.54 ± 2.21. There were no adverse effects and abnormalities in paraclinical parameters with INK therapy. The results of our study suggest that INK dietary supplement is effective and safe phytotherapy for patients with primary OAB symptoms within 30 days of treatment. Larger control clinical trials are warranted to confirm our findings and promote wider use of INK for OAB and possible other age-related urination disorders.


Subject(s)
Urinary Bladder, Overactive , Humans , Infant , Urinary Bladder, Overactive/drug therapy , Urinary Bladder, Overactive/diagnosis , Urination , Treatment Outcome , Sleep , Quality of Life
2.
Front Psychiatry ; 13: 987686, 2022.
Article in English | MEDLINE | ID: mdl-36386986

ABSTRACT

Background: The COVID-19 pandemic has affected health and well-being worldwide, and its psychological effects are receiving substantial attention in the scientific literature. Research to date shows that the pandemic has increased prevalences of depression, anxiety, and stress. This study aimed to estimate the prevalence of mental health symptoms and identify the associated factors among men in a rural area of Vietnam during the COVID-19 pandemic. Methods and findings: During July 15-31, 2020, we conducted a cross-sectional survey of 1,085 men from 18 years old in 11 rural districts in Thanh Hoa province, Vietnam, and assessed their mental health using the Depression, Anxiety and Stress Scale - 21 Items (DASS-21). Outcomes assessed were have a symptom of depression, anxiety, and stress; risk factors measured included age, religion, marital status, education, occupation, and financial status. Multiple linear regression was performed to determine the statistical significance of associations between risk factors and mental health symptoms. Findings showed that the prevalences of having a symptom of depression, anxiety and stress among participants were 6.39, 9.72, and 5.65%, respectively. Regression model showed being younger (95% CI: -0.030; -0.004, p = 0.001), men had high school degree (95% CI: -0.671; -0.074, p = 0.014), men living in nearly poor houshoulds (95% CI: 0.067, 1.905, p < 0.05) and poor housholds (95% CI: 0.608; 2.721, p < 0.05) had significantly lower depression scores than others. Conclusion: Prevalences of having symptoms of depression, anxiety and stress were much higher than in similar previous research in rural Vietnam, suggesting that mental health problems among men in this setting became more common during the COVID-19 pandemic. Age, religion, level of education and family income status were statistically significant predictors of mental health problems. These findings provide useful insights into the impact of pandemics on mental health.

3.
Eur J Med Chem ; 244: 114837, 2022 Dec 15.
Article in English | MEDLINE | ID: mdl-36265279

ABSTRACT

The toxic pyroglutamate form of amyloid-ß (pE-Aß) is important for the pathogenesis of early Alzheimer's disease (AD); therefore, reducing pE-Aß by inhibiting glutaminyl cyclase (QC) provides a promising strategy for developing disease-modifying AD drugs. In this study, potent and selective QC inhibitors with desirable drug-like properties were discovered by replacing the 3,4-dimethoxyphenyl group in a QC inhibitor with a bioisosteric indazole surrogate. Among them, 3-methylindazole-6-yl and 3-methylindazole-5-yl derivatives with an N-cyclohexylurea were identified as highly potent inhibitors with IC50 values of 3.2 nM and 2.3 nM, respectively, both of which were approximately 10-fold more potent than varoglutamstat. In addition, the three inhibitors significantly reduced pE-Aß3-40 levels in an acute animal model after intracerebroventricular (icv) injection and were selective for hQC. Further in vitro pharmacokinetic and toxicity studies, including those investigating cytotoxicity, hERG inhibition, blood-brain barrier (BBB) permeability and metabolic stability, indicated that N-(3-methylindazole-6-yl)-N'-(cyclohexyl)urea derivative exhibited the most promising efficacy, selectivity and drug-like profile; thus, it was evaluated for its in vivo efficacy in an AD model.


Subject(s)
Alzheimer Disease , Aminoacyltransferases , Drug Discovery , Indazoles , Animals , Humans , Alzheimer Disease/enzymology , Aminoacyltransferases/antagonists & inhibitors , Aminoacyltransferases/chemistry , Amyloid beta-Peptides/metabolism , Indazoles/chemistry , Indazoles/pharmacology
4.
Eur J Protistol ; 86: 125933, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36308895

ABSTRACT

This study provides new data on ecology of testate amoebae in the waterbodies of the Central Highlands and South-Central Coast regions of Vietnam. A total of 108 species and subspecies including six new records for Vietnam were identified. One new species Difflugia quangtrani sp. nov. was described. Difflugia, Arcella, and Centropyxis were the most species-rich genera, and Centropyxis aculeata was the most common species. The results of NMDS and ANOSIM analyses for the first time showed significant differences in composition of tropical freshwater testate amoeba communities within both various types of waterbodies (reservoir, river, and wetland) and biotopes (plankton and benthos). Average species richness per sample in different types of waterbodies was similar, while that of plankton was statistically higher than in benthos. The distance decay of similarity in tropical freshwater testate amoeba community of both plankton and benthos was observed for the first time indicating the importance of geographical distance in testacean species composition changes between samples. Redundancy analyses followed by the forward selection have determined elevation, pH, and dissolved oxygen as significant factors that affect tropical freshwater testacean community. More large-scale climatic and small-scale hydrological and hydrochemical variables should be included into further studies to find out most important factors determining structure of freshwater testacean assemblages.


Subject(s)
Amoeba , Biodiversity , Vietnam , Ecology , Hydrology , Plankton
5.
Nanomedicine ; 44: 102576, 2022 08.
Article in English | MEDLINE | ID: mdl-35714922

ABSTRACT

Targeting microglial activation is emerging as a clinically promising drug target for neuropathic pain treatment. Fexofenadine, a histamine receptor 1 antagonist, is a clinical drug for the management of allergic reactions as well as pain and inflammation. However, the effect of fexofenadine on microglial activation and pain behaviors remains elucidated. Here, we investigated nanomedicinal approach that targets more preferentially microglia and long-term analgesics. Fexofenadine significantly abolished histamine-induced microglial activation. The fexofenadine-encapsulated poly(lactic-co-glycolic acid) nanoparticles (Fexo NPs) injection reduced the pain sensitivity of spinal nerve ligation rats in a dose-dependent manner. This alleviation was sustained for 4 days, whereas the effective period by direct fexofenadine injection was 3 h. Moreover, Fexo NPs inhibited microglial activation, inflammatory signaling, cytokine release, and a macrophage phenotype shift towards the alternative activated state in the spinal cord. These results show that Fexo NPs exhibit drug repositioning promise as a long-term treatment modality for neuropathic pain.


Subject(s)
Nanoparticles , Neuralgia , Animals , Microglia , Neuralgia/genetics , Rats , Spinal Cord , Spinal Nerves , Terfenadine/analogs & derivatives
6.
ACS Appl Mater Interfaces ; 13(45): 53829-53840, 2021 Nov 17.
Article in English | MEDLINE | ID: mdl-34726907

ABSTRACT

The present environmental crisis prompts the search for renewable energy sources such as solar-driven production of hydrogen from water. Herein, we report an efficient hybrid photocatalyst for water oxidation, consisting of a ruthenium polypyridyl complex covalently grafted on core/shell Fe@FeOx nanoparticles via a phosphonic acid group. The photoelectrochemical measurements were performed under 1 sun illumination in 1 M KOH. The photocurrent density of this hybrid photoanode reached 20 µA/cm2 (applied potential of +1.0 V vs reversible hydrogen electrode), corresponding to a turnover frequency of 0.02 s-1. This performance represents a 9-fold enhancement of that achieved with a mixture of Fe@FeOx nanoparticles and a linker-free ruthenium polypyridyl photosensitizer. This increase in performance could be attributed to a more efficient electron transfer between the ruthenium photosensitizer and the Fe@FeOx catalyst as a consequence of the covalent link between these two species through the phosphonate pendant group.

7.
Eur J Med Chem ; 226: 113819, 2021 Dec 15.
Article in English | MEDLINE | ID: mdl-34536669

ABSTRACT

The inhibition of glutaminyl cyclase (QC) may provide a promising strategy for the treatment of early Alzheimer's disease (AD) by reducing the amount of the toxic pyroform of ß-amyloid (AßΝ3pE) in the brains of AD patients. In this work, we identified potent QC inhibitors with subnanomolar IC50 values that were up to 290-fold higher than that of PQ912, which is currently being tested in Phase II clinical trials. Among the tested compounds, the cyclopentylmethyl derivative (214) exhibited the most potent in vitro activity (IC50 = 0.1 nM), while benzimidazole (227) showed the most promising in vivo efficacy, selectivity and druggable profile. 227 significantly reduced the concentration of pyroform Aß and total Aß in the brain of an AD animal model and improved the alternation behavior of mice during Y-maze tests. The crystal structure of human QC (hQC) in complex with 214 indicated tight binding at the active site, supporting that the specific inhibition of QC results in potent in vitro and in vivo activity. Considering the recent clinical success of donanemab, which targets AßΝ3pE, small molecule-based QC inhibitors may also provide potential therapeutic options for early-stage AD treatment.


Subject(s)
Alzheimer Disease/drug therapy , Aminoacyltransferases/antagonists & inhibitors , Benzimidazoles/pharmacology , Cyclopentanes/pharmacology , Enzyme Inhibitors/pharmacology , Neuroprotective Agents/pharmacology , Alzheimer Disease/metabolism , Aminoacyltransferases/metabolism , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/metabolism , Animals , Benzimidazoles/chemical synthesis , Benzimidazoles/chemistry , Cyclopentanes/chemical synthesis , Cyclopentanes/chemistry , Dose-Response Relationship, Drug , Drug Discovery , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Humans , Male , Mice , Mice, Inbred ICR , Molecular Structure , Neuroprotective Agents/chemical synthesis , Neuroprotective Agents/chemistry , Structure-Activity Relationship
8.
Spectrochim Acta A Mol Biomol Spectrosc ; 259: 119853, 2021 Oct 05.
Article in English | MEDLINE | ID: mdl-33971437

ABSTRACT

The determination of the abundances of the CHx, C = O and aromatic groups in chondritic Insoluble Organic Matter (IOM) and coals by Infrared (IR) spectroscopy is a challenging issue due to insufficient knowledge on the absorption cross-sections and their sensitivity to the molecular environment. Here, we report a calibration approach based on a 13C synthetic model material whose composition was unambiguously determined by Direct-Pulse/Magic Angle Spinning Nuclear Magnetic Resonance (DP/MAS NMR). Ratios of the cross-sections of the CHx, C = O and aromatic groups have been determined, and the method has been applied to IOM samples extracted from four chondrites as Orgueil (CI), Murchison (CM), Tagish Lake (C2-ungrouped) and EET 92042 (CR2), and to a series of coals. The estimate of the aliphatic to aromatic carbon ratio (nCHx/nAro) in IOM samples from Orgueil, Murchison and Tagish Lake chondrites is in good agreement with Single-Pulse/NMR estimates earlier published, and is lower by a factor of 1.3 in the case of the CR chondrite EET 92042 (but the error bars overlap). In contrast, the aliphatic to carbonyl ratio (nCHx/nC=O) is overestimated for the four chondrites. These discrepancies are likely due to the control of the absorption cross-section of the C = O and C = C bonds by the local molecular environment. Regarding coals, the use of published NMR analyses has brought to light that the integrated cross-section ratio ACHx/AAro varies with the vitrinite reflectance over an order of magnitude. Here as well, the local oxygen speciation plays a critical control in AAro, which decreases with increasing the vitrinite reflectance. We provide an analytical law that links ACHx/AAro and vitrinite reflectance, which will allow the determination of nCHx/nAro for any coal sample, provided its vitrinite reflectance is known.

9.
Sci Rep ; 10(1): 6919, 2020 04 24.
Article in English | MEDLINE | ID: mdl-32332814

ABSTRACT

To accelerate the cardiac drug discovery pipeline, we set out to develop a platform that would be capable of quantifying tissue-level functions such as contractile force and be amenable to standard multiwell-plate manipulations. We report a 96-well-based array of 3D human pluripotent stem cell (hPSC)-derived cardiac microtissues - termed Cardiac MicroRings (CaMiRi) - in custom 3D-print-molded multiwell plates capable of contractile force measurement. Within each well, two elastomeric microcantilevers are situated above a circumferential ramp. The wells are seeded with cell-laden collagen, which, in response to the gradual slope of the circumferential ramp, self-organizes around tip-gated microcantilevers to form contracting CaMiRi. The contractile force exerted by the CaMiRi is measured and calculated using the deflection of the cantilevers. Platform responses were robust and comparable across wells, and we used it to determine an optimal tissue formulation. We validated the contractile force response of CaMiRi using selected cardiotropic compounds with known effects. Additionally, we developed automated protocols for CaMiRi seeding, image acquisition, and analysis to enable the measurement of contractile force with increased throughput. The unique tissue fabrication properties of the platform, and the consequent effects on tissue function, were demonstrated upon adding hPSC-derived epicardial cells to the system. This platform represents an open-source contractile force screening system useful for drug screening and tissue engineering applications.


Subject(s)
Pluripotent Stem Cells/cytology , Tissue Engineering/methods , Animals , Automation , Cardiotonic Agents/pharmacology , Cells, Cultured , Heart/drug effects , Heart/physiology , Humans , Mice , Myocardial Contraction/drug effects , Pluripotent Stem Cells/drug effects , Printing, Three-Dimensional
10.
Chemosphere ; 242: 125174, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31675582

ABSTRACT

Salt marshes are natural deposits of heavy metals in estuarine systems, where sulphide precipitation associated with redox changes often results in a natural attenuation of contamination. In the present study, we focus on the effects of variable redox conditions imposed to a highly-polluted phosphogypsum stack that is directly piled over the salt marsh soil in the Tinto River estuary (Huelva, Spain). The behaviour of contaminants is evaluated in the phosphogypsum waste and in the marsh basement, separately, in controlled, experimentally-induced oscillating redox conditions. The results revealed that Fe, and to a lesser extent S, control most precipitation/dissolution processes. Ferric iron precipitates in the form of phosphates and oxyhydroxides, while metal sulphide precipitation is insignificant and appears to be prevented by the abundant formation of Fe phosphates. An antagonistic evolution with changing redox conditions was observed for the remaining contaminants such as Zn, As, Cd and U, which remained mobile in solution during most of experimental run. Therefore, these findings revealed that high concentrations of phosphates inhibit the typical processes of immobilisation of pollutants in salt-marshes which highlights the elevated contaminant potential of phosphogypsum wastes on coastal environments.


Subject(s)
Calcium Sulfate/chemistry , Estuaries , Oxidation-Reduction , Phosphorus/chemistry , Environmental Monitoring/methods , Iron/chemistry , Metals, Heavy/analysis , Phosphates/chemistry , Rivers , Spain , Water Pollutants, Chemical/analysis , Wetlands
11.
J Med Chem ; 62(17): 8011-8027, 2019 09 12.
Article in English | MEDLINE | ID: mdl-31411468

ABSTRACT

Alzheimer's disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for alternative approaches to tackle the multifaceted aspects of AD. Among the potential alternative targets, we aim to focus on glutaminyl cyclase (QC), which reduces the toxic pyroform of ß-amyloid in the brains of AD patients. On the basis of a putative active conformation of the prototype inhibitor 1, a series of N-substituted thiourea, urea, and α-substituted amide derivatives were developed. The structure-activity relationship analyses indicated that conformationally restrained inhibitors demonstrated much improved QC inhibition in vitro compared to nonrestricted analogues, and several selected compounds demonstrated desirable therapeutic activity in an AD mouse model. The conformational analysis of a representative inhibitor indicated that the inhibitor appeared to maintain the Z-E conformation at the active site, as it is critical for its potent activity.


Subject(s)
Alzheimer Disease/drug therapy , Aminoacyltransferases/antagonists & inhibitors , Anti-Anxiety Agents/pharmacology , Drug Discovery , Enzyme Inhibitors/pharmacology , Alzheimer Disease/metabolism , Aminoacyltransferases/metabolism , Animals , Anti-Anxiety Agents/chemical synthesis , Anti-Anxiety Agents/chemistry , Cell Line , Cell Survival/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Humans , Mice , Mice, Inbred ICR , Molecular Structure , Quantum Theory , Structure-Activity Relationship
12.
Sci Total Environ ; 663: 718-730, 2019 May 01.
Article in English | MEDLINE | ID: mdl-30731417

ABSTRACT

The impact of seasonal fluctuations linked to monsoon and irrigation generates redox oscillations in the subsurface, influencing the release of arsenic (As) in aquifers. Here, the biogeochemical control on As mobility was investigated in batch experiments using redox cycling bioreactors and As- and SO42--amended sediment. Redox potential (Eh) oscillations between anoxic (-300-0 mV) and oxic condition (0-500 mV) were implemented by automatically modulating an admixture of N2/CO2 or compressed air. A carbon source (cellobiose, a monomer of cellulose) was added at the beginning of each reducing cycle to stimulate the metabolism of the native microbial community. Results show that successive redox cycles can decrease arsenic mobility by up to 92% during reducing conditions. Anoxic conditions drive mainly the conversion of soluble As(V) to As(III) in contrast to oxic conditions. Phylogenetic analyses of 16S rRNA amplified from the sediments revealed the presence of sulfate and iron - reducing bacteria, confirming that sulfate and iron reduction are key factors for As immobilization from the aqueous phase. As and S K-edge X-ray absorption spectroscopy suggested the association of Fe-(oxyhydr)oxides and the importance of pyrite (FeS2(s)), rather than poorly ordered mackinawite (FeS(s)), for As sequestration under oxidizing and reducing conditions, respectively. Finally, these findings suggest a role for elemental sulfur in mediating aqueous thioarsenates formation in As-contaminated groundwater of the Mekong delta.


Subject(s)
Arsenic/analysis , Bacteria/metabolism , Environmental Monitoring , Groundwater/chemistry , Sulfates/metabolism , Water Pollutants, Chemical/analysis , Bioreactors , Oxidation-Reduction , Vietnam , X-Ray Absorption Spectroscopy
13.
Bioorg Med Chem ; 26(12): 3133-3144, 2018 07 23.
Article in English | MEDLINE | ID: mdl-29705377

ABSTRACT

Glutamyl cyclase (QC) is a promising therapeutic target because of its involvement in the pathogenesis of Alzheimer's disease. In this study, we developed novel QC inhibitors that contain 3-aminoalkyloxy-4-methoxyphenyl and 4-aminoalkyloxyphenyl groups to replace the previously developed pharmacophore. Several potent inhibitors were identified, showing IC50 values in a low nanomolar range, and were further studied for in vitro toxicity and in vivo activity. Among these, inhibitors 51 and 53 displayed the most potent AßN3pE-40-lowering effects in in vivo acute model with reasonable BBB penetration, without showing cytotoxicity and hERG inhibition. The molecular modeling analysis of 53 indicated that the salt bridge interaction and the hydrogen bonding in the active site provided a high potency. Given the potent activity and favorable BBB penetration with low cytotoxicity, we believe that compound 53 may serve as a potential candidate for anti-Alzheimer's agents.


Subject(s)
Aminoacyltransferases/antagonists & inhibitors , Enzyme Inhibitors/chemistry , Aminoacyltransferases/metabolism , Amyloid beta-Peptides/metabolism , Binding Sites , Blood-Brain Barrier/metabolism , Catalytic Domain , Dipeptides/chemistry , Drug Design , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Humans , Hydrogen Bonding , Inhibitory Concentration 50 , Molecular Docking Simulation , Permeability/drug effects , Structure-Activity Relationship
14.
Bioorg Med Chem ; 26(5): 1035-1049, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29398442

ABSTRACT

Pyroglutamate-modified amyloid ß peptides (pGlu-Aß) are highly neurotoxic and promote the formation of amyloid plaques. The pGlu-Aß peptides are generated by glutaminyl cyclase (QC), and recent clinical studies indicate that QC represents an alternative therapeutic target to treat Alzheimer's disease (AD). We have previously developed a series of QC inhibitors with an extended pharmacophoric scaffold, termed the Arg-mimetic D-region. In the present study, we focused on the structure activity relationship (SAR) of analogues with modifications in the D-region and evaluated their biological activity. Most compounds in this series exhibited potent activity in vitro, and our SAR analysis and the molecular docking studies identified compound 202 as a potential candidate because it forms an additional hydrophobic interaction in the hQC active site. Overall, our study provides valuable insights into the Arg-mimetic pharmacophore that will guide the design of novel QC inhibitors as potential treatments for AD.


Subject(s)
Aminoacyltransferases/antagonists & inhibitors , Enzyme Inhibitors/chemistry , Alzheimer Disease/drug therapy , Alzheimer Disease/pathology , Aminoacyltransferases/metabolism , Amyloid beta-Peptides/administration & dosage , Amyloid beta-Peptides/analysis , Animals , Binding Sites , Brain/enzymology , Catalytic Domain , Cell Line , Drug Design , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/therapeutic use , Humans , Hydrophobic and Hydrophilic Interactions , Male , Mice , Mice, Inbred ICR , Molecular Docking Simulation , Structure-Activity Relationship
15.
Am J Cardiol ; 120(8): 1223-1229, 2017 Oct 15.
Article in English | MEDLINE | ID: mdl-28822562

ABSTRACT

Given the proven effectiveness of several cardiac medications for patients with coronary artery disease (CAD), we examined the national use of 4 classes of effective medications, overall and by age, sex, and race/ethnicity in 2005 to 2014. We used data from the National Health and Nutrition Examination Survey, including a self-reported diagnosis of CAD and independently verified medication use. Weighting procedures extrapolated our data to the adult US population with CAD. Analyses included 1,789 US adults aged ≥45 years with a history of CAD. The average age of this population was 68 years; 40% were women and 79% were non-Hispanic whites. In 2005 to 2014, 53.2% (standard error [SE] = 1.5) reported use of angiotensin-converting enzyme inhibitor/angiotensin receptor blockers, 58.5% (SE = 1.5) ß blockers, and 67.2% (SE = 1.4) statins. Two of these medications were used by 64.1% (SE = 1.5) of the study population and all 3 by 29.1% (SE = 1.3). In 2011 to 2014, 68.5% (SE = 2.4) of American adults with a history of CAD reported use of aspirin. The use of statins increased from 63.1% in 2005/2006 to 76.8% in 2013/2014. Adults aged 45 to 64 years old, women, and racial/ethnic minorities had lower use of effective cardiac medications compared with older adults, men, and non-Hispanic whites. In conclusion, the use of statins, but not other medications, has increased over the past 10 years among American adults with previously diagnosed CAD. Continued targeted efforts are needed to increase the receipt of effective cardiac medications among all US adults with CAD, especially those aged 45 to 64 years, women, and racial/ethnic minorities.


Subject(s)
Acute Coronary Syndrome/drug therapy , Cardiovascular Agents/therapeutic use , Drug Utilization/statistics & numerical data , Ethnicity , Healthcare Disparities/ethnology , Nutrition Surveys/methods , Racial Groups , Acute Coronary Syndrome/ethnology , Aged , Female , Humans , Male , Medication Adherence/ethnology , Medication Adherence/statistics & numerical data , Middle Aged , Prevalence , Registries , Retrospective Studies , United States/epidemiology
16.
J Med Chem ; 60(6): 2573-2590, 2017 03 23.
Article in English | MEDLINE | ID: mdl-28234463

ABSTRACT

Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of ß-amyloid peptides (pGlu-Aß) and thus may participate in the pathogenesis of Alzheimer's disease (AD). We designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aß3E-42. An in vitro structure-activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor. When tested in mouse models of AD, compound 212 significantly reduced the brain concentrations of pyroform Aß and total Aß and restored cognitive functions. This potent Aß-lowering effect was achieved by incorporating an additional binding region into our previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu327 in the QC binding site. Our study offers useful insights in designing novel QC inhibitors as a potential treatment option for AD.


Subject(s)
Alzheimer Disease/drug therapy , Aminoacyltransferases/antagonists & inhibitors , Amyloid beta-Peptides/antagonists & inhibitors , Drug Design , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/therapeutic use , Alzheimer Disease/metabolism , Aminoacyltransferases/chemistry , Aminoacyltransferases/metabolism , Amyloid beta-Peptides/metabolism , Animals , Benzene Derivatives/chemistry , Benzene Derivatives/pharmacology , Benzene Derivatives/therapeutic use , Enzyme Inhibitors/pharmacology , Humans , Male , Mice , Mice, Inbred ICR , Molecular Docking Simulation
17.
Bioorg Med Chem Lett ; 25(11): 2326-30, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-25937016

ABSTRACT

A series of α-substituted acetamide derivatives of previously reported 2-(3-fluoro-4-methylsulfonamidophenyl)propanamide leads (1, 2) were investigated for antagonism of hTRPV1 activation by capsaicin. Compound 34, which possesses an α-m-tolyl substituent, showed highly potent and selective antagonism of capsaicin with Ki(CAP)=0.1 nM. It thus reflected a 3-fold improvement in potency over parent 1. Docking analysis using our homology model indicated that the high potency of 34 might be attributed to a specific hydrophobic interaction of the m-tolyl group with the receptor.


Subject(s)
Acetamides/pharmacology , TRPV Cation Channels/antagonists & inhibitors , Acetamides/chemistry , Animals , CHO Cells , Capsaicin/pharmacology , Cricetinae , Cricetulus , Molecular Structure , Structure-Activity Relationship , TRPV Cation Channels/metabolism
18.
J Org Chem ; 72(6): 1957-61, 2007 Mar 16.
Article in English | MEDLINE | ID: mdl-17286437

ABSTRACT

A variety of 1,3,5-tricarbonyl derivatives were prepared by reaction of 1,3-bis(silyl enol ethers) with acid chlorides under mild conditions. This includes reactions of both aromatic and aliphatic acid chlorides and bis(acid chlorides). The yields vary depending on the type of acid chloride employed.


Subject(s)
Ether/chemistry , Silanes/chemistry , Acids/chemistry , Organometallic Compounds/chemical synthesis
19.
Ann N Y Acad Sci ; 1081: 531-3, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17135564

ABSTRACT

Edema disease caused by Escherichia coli is one of the most common diseases in postweaning piglets throughout Vietnam. Verotoxigenic E. coli (VTEC) was isolated from 197 of 261 samples (75.5%). All isolates were confirmed by basic biochemical tests and carbohydrate fermentation characteristics. Of these, 70.1% of isolates are hemolytic, 45% isolates belonged to serotypes O149:K91, possessed the VT2e gene, and was the most predominant VTEC pathotype associated with edema disease in pigs. Serogroup O139 accounted for 30% of the isolates, followed by serogroup O138 and O141 (25%). In addition to VT2e gene, the ST (72.7%) and LT (52.7%) genes were also recognized. A total of 10 representative isolates were subjected to toxigenicity testing by intraperitoneal injection in mice and experimental infection in pigs. It was shown that 100% of the mice were killed 17-24 h post injection (p.i.). All pigs experimentally infected with challenge strains and developed typical symptoms of edema disease 36-72 h p.i. A multivalent killed whole-cells vaccine containing aluminum hydroxide was prepared from 5 VTEC strains. The vaccine was 100% safe when administered by the intramuscular route into the pigs. A field trial for over 100,000 pigs (21-90 days old) showed that vaccinated pigs were protected against edema disease at a level of 90% compared to 100% of pigs from unvaccinated groups.


Subject(s)
Bacterial Vaccines , Edema Disease of Swine/microbiology , Edema Disease of Swine/prevention & control , Escherichia coli Infections/veterinary , Swine Diseases/prevention & control , Animals , Bacterial Vaccines/immunology , Diarrhea/microbiology , Diarrhea/prevention & control , Diarrhea/veterinary , Escherichia coli/genetics , Escherichia coli/isolation & purification , Escherichia coli/pathogenicity , Escherichia coli Infections/microbiology , Escherichia coli Infections/prevention & control , Hemolysis , O Antigens/analysis , Serotyping , Swine , Swine Diseases/microbiology , Vietnam , Weaning
20.
Ann N Y Acad Sci ; 1081: 543-5, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17135566

ABSTRACT

Both disk diffusion and broth micro-dilution assays were employed to determine the level of resistance in Enterotoxigenic Escherichia coli (ETEC) isolates (n = 170) obtained from preweaning piglet colibacillosis from the two different pig production systems (commercial piggeries and small holder farmers) in Vietnam. Overall, tetracycline, streptomycin, amoxicillin, trimethoprim/sulfamethoxazole, and chloramphenicol showed markedly higher rates of resistance. Both apramycin and ceftiofur are active against all ETEC isolates. These antimicrobials could be recommended as the drugs of choice for the treatment of E. coli infections in young pigs in North Vietnam. Resistance to third-generation cephalosporin (ceftiofur, ceftazidime, and cefoxitin) was not observed in Vietnamese ETEC isolates. Multiple resistances to greater than three antimicrobials were widely distributed (approximately 79.4%).


Subject(s)
Anti-Bacterial Agents/pharmacology , Diarrhea/veterinary , Drug Resistance, Bacterial , Escherichia coli Infections/veterinary , Escherichia coli/drug effects , Swine Diseases/microbiology , Animal Husbandry , Animals , Animals, Newborn , Diarrhea/drug therapy , Diarrhea/microbiology , Drug Resistance, Multiple, Bacterial , Escherichia coli/classification , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Microbial Sensitivity Tests/veterinary , Phenotype , Swine , Swine Diseases/drug therapy , Vietnam , Weaning
SELECTION OF CITATIONS
SEARCH DETAIL
...